{"slideshow_credits": null, "snippet": "GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year.", "abstract": "GlaxoSmithKline plans to cut costs in its struggling European drugs division and promises investors a return to growth in 2013; reports fourth-quarter profit of 839 million pounds ($1.35 billion), down 35 percent from 1.28 billion pounds in year-ago quarter; revenue fell 3 percent to 6.80 billion pounds.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/02/07/business/after-posting-lower-profit-glaxo-to-cut-costs.html", "lead_paragraph": "GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year.", "headline": {"seo": "After Posting Lower Profit, Glaxo to Cut Costs", "main": "Glaxo Plans to Cut Costs to Offset Weak Sales", "print_headline": "Glaxo Plans To Cut Costs To Offset Weak Sales"}, "_id": "5118923800315214fbb8a538", "word_count": "304", "multimedia": [], "pub_date": "2013-02-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Company Reports", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Europe", "name": "glocations", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}